| Name | Title | Contact Details |
|---|
Allegro Development Corporation is a maker of commodity management software for power and gas utilities; refiners, producers and traders of crude oil, refined products, soft commodities and agricultural commodities; and industrial energy consumers.
Tapad is the leader in cross-device content delivery. Our groundbreaking, proprietary technology assimilates billions of data points to find the human relationship between smartphones, desktops, laptops, tablets, connected TVs and game consoles. The result: an unprecedented understanding of consumer behavior across related screens and the ability to reach the right people on the right device at the right time. With Tapad, publishers and advertisers can deepen consumer engagement with a more fluid experience while increasing campaign cost-effectiveness. Backed by major venture firms, Tapad is based in New York and has offices in Atlanta, Chicago, Dallas, Detroit, Los Angeles, Miami and San Francisco. TechCrunch called the powerhouse Tapad team “a hell of a list of entrepreneurs who created some of the most valuable online advertising companies of the last decade.”
MDSL leads the market in global Technology Expense Management and Market Data Management solutions. Request a demo of MDSL’s software and managed service solutions today.
Syntergy is a La Jolla, CA-based company in the Software and Internet sector.
Visualant is a public company whose shares trade under the stock symbol, VSUL. The Visualant Spectral Pattern Matching technology directs structured light onto a substance, through a liquid/gas, or off a surface, to capture a unique ChromaID™. When matched against existing databases, a ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID ScanHead modules can be integrated into a variety of mobile or fixed-mount form factors. The patented technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab–based tests.